Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pronase for Mucosal Clarity in Colitis Colonoscopy
NCT06874673Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of pronase in Colitis and inflammatory bowel disease (IBD) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Improvement rate of intestinal mucosal clarity after rinsing. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
pronase
03
Conditions
Colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT06874673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06874673.